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Abstract 
 
Background: There is some debate regarding the utility of Attention-Deficit/ Hyperactivity Disorder (ADHD) subtypes as 
currently defined. Differences in co-occurring psychopathology among subtypes would support the validity of subtype defini-
tions.  
Objective: To explore how ADHD subtype relates to co-occurring psychopathology in a large population-based sample of 
children and adolescents (n=5744). 
Method: Parents completed the Strengths and Weaknesses of ADHD-symptoms and Normal behavior (SWAN) questionnaire, 
the Child Behavior Checklist (CBCL) and the Social Responsiveness Scale (SRS). Methods including discriminant analysis, prin-
cipal components analysis, and fractional polynomial regression were used to examine the relationship between ADHD diagnos-
tic subtypes and co-occurring psychopathology. 
Results: Children with different ADHD subtypes show differences on several CBCL subscales. A combination of CBCL sub-
scales and SRS score had good ability to discriminate ADHD subtypes. Conversely, for the same overall number of ADHD 
symptoms, individuals who present with both inattentive and hyperactive/impulsive symptoms exhibit higher severity of co-
occurring psychopathology on a summary measure derived from principal components analysis of the CBCL subscales and SRS. 
This includes some subjects who fail to meet the DSM-IV-TR ADHD symptom criterion due to having less than 6 inattentive 
and less than six hyperactive-impulsive symptoms, yet have ADHD symptom severity similar to those with the inattentive or 
hyperactive-impulsive subtype. 
Conclusions: Several convergent lines of analysis provide support for the continued use of ADHD subtypes (or current presen-
tation symptom profiles), as evidenced by differences in co-existing psychopathlogy. We also found that current diagnostic crite-
ria may fail to identify a potentially impaired group of individuals who have low-to-moderate levels of both inattention and hy-
peractivity/impulsivity. Under the upcoming DSM-5, it will be important for clinicians to consider the option of giving an 
ADHD “not elsewhere classified” diagnosis to such children. 
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Introduction 
There is some debate regarding the current DSM-IV-
TR criteria for Attention-Deficit/Hyperactivity Dis-
order (ADHD) and its three subtypes (predominantly 
inattentive, predominantly hyperactive-impulsive, and 
combined type). First, the correlation between the 
inattentive and hyperactive-impulsive domains is very 
high, with evidence of high genetic overlap between 
separate ADHD subtypes or symptom dimensions 
(1). Second, from a clinical intervention standpoint, 
stimulants are the mainstay of pharmacological treat-
ment, regardless of subtype (though educational ac-
commodations will vary slightly depending on which 
type of symptoms predominate in the school setting). 
Third, children who present with a meaningful six to 
ten symptoms could potentially qualify for the inat-
tentive subtype or the hyperactive-impulsive subtype, 
provided that six or more of these symptoms fall into 
one category. A more likely event, given the high 
correlation between the two domains, is that the 
symptoms would be roughly equally divided, so that 
the child would not technically qualify for a diagnosis 
of ADHD (e.g., five symptoms in each category). 
Below, we will present data suggesting significant 
impairment in such children. Improved definition and 
screening methods for ADHD and its subtypes may 
help ensure that individuals with clinically impairing 
ADHD symptoms can be identified and treated. 
Differences in external (non-ADHD) measures 
(such as cognitive profiles, genetic associations, and 
comorbidity patterns) among ADHD subtypes would 
help validate the current typology. They may suggest 
differences in etiology and treatment needs between 
ADHD subtypes. Also, if different ADHD subtypes 
are associated with different types of co-occurring 
problems and/or different levels of severity, this may 
support subtypes as prognostic indicators to guide the 
monitoring of specific types of co-occurring problems 
depending upon the ADHD symptom profile. 
The Child Behavior Checklist has previously been 
used to examine comorbid psychopathology in chil-
dren with ADHD (2-5). Some studies specifically 
examined differences in CBCL measures among 
ADHD subtypes (3, 5). Though results vary some-
what between studies, individuals with the combined 
subtype generally have the highest rates of co-
occurring psychopathology where subtype differences 
are found. 
Population-based studies conducted by our own re-
search group investigated the validity of ADHD sub-
types through analyses focusing on prevalence (6), sex 
differences (6), cognitive function (7), comorbidity 
profiles (8-10), genetics (11-13), and longitudinal 
course (14). In these analyses, subtypes were defined 
both according to DSM-IV criteria and via Latent 
Class Analysis (LCA), a form of mixture modeling 
that can be used to separate subjects into discrete, 
more homogeneous groups characterized by specific 
symptom profiles. Three of these latent classes (la-
beled severe inattentive, mild combined, and severe 
combined) show substantial evidence of impairment 
(5), while those characterized by pure hyperactive-
impulsive symptoms show little evidence of impair-
ment. The severe inattentive type shows modest 
agreement with DSM-IV inattentive subtype, and the 
severe combined type shows excellent agreement with 
DSM-IV combined subtype ADHD (8, 15-18). These 
previous analyses supported inattentive ADHD as a 
distinct subgroup based on genetic associations and 
co-occurring problems (5, 7, 8, 11-13), but failed to 
take into account the fact that overall severity of 
combined type ADHD compared to inattentive 
ADHD could account for many of the differences 
between these two subtypes. 
In a prospective longitudinal study of twins, we 
found that compared to the inattentive subtype, the 
diagnosis of combined subtype ADHD (defined by 
either DSM or LCA) is more stable over time than 
other subtype diagnoses (14). While combined sub-
type subjects sometimes switched to inattentive sub-
type five years later, inattentive subjects tended to 
remain inattentive if they still had a diagnosis five 
years later. Again, overall severity could underlie the 
difference in subtype stability since children with 
more severe forms of a neurodevelopmental disorder 
(i.e. combined type ADHD) may be expected to have 
more persistent symptoms over time. Hurtig and 
colleagues reach a similar conclusion based on a retro-
spective study (19). For DSM-5, it has been proposed 
that ADHD subtypes be replaced by similarly defined 
“specifiers” of current presentation, in part to empha-
size that these categories represent current symptom 
profile rather than longitudinally stable subtypes (20). 
Even though the concept of subtypes will be de-
emphasized by this change, DSM-5 will likely still 
require six symptoms in at least one of the two symp-
tom domains in order to meet the overall symptom 
criterion. A diagnosis of “ADHD Not Elsewhere 
Classified” has been proposed to classify individuals 
who do not meet the full symptom criterion due to 
partial remission status or clinically significant but 
subthreshold symptoms (e.g., those with five symp-
toms in each category) (20). 
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Using additional population-based data from a large 
sibship sample, the current analysis attempts to fur-
ther explore the validity of ADHD subtype defini-
tions through the examination of co-occurring psy-
chopathology. If, for example, when controlling for 
overall severity of total ADHD symptoms, individuals 
with the inattentive ADHD subtype are more severely 
affected than combined type on any specific measures 
of co-occurring psychopathology, this would suggest 
that inattentive ADHD is a distinct subtype rather 
than just a less severe form of combined type ADHD. 
Our focus on population-based samples avoids some 
of the biases inherent to clinical samples. In particular, 
children with hyperactive-impulsive symptoms may be 
brought to clinical attention due to their disruptive 
behavior at school, while children with predominantly 
inattentive ADHD (especially those without addi-
tional psychopathology warranting clinical attention) 
may be overlooked because they do not disrupt the 
classroom. 
 
 
Methods  
Sample  
Subjects are from the Missouri Large Sibship Sample 
(MO-BIGSIBS). Families with four or more children 
born in the state of Missouri were identified for study 
using a birth records database (21). As the parent 
study required genetic material from both parents in a 
later phase, we only screened families in which both 
biological parents were available (parents could not be 
deceased or in prison). Families were excluded at the 
birth records review or tracking level if the family was 
known to have twins (due to other studies using twin 
samples), language difficulty that would prevent Eng-
lish-language telephone screening, or if a parent was 
deceased. Individual children were excluded during 
the parent-report telephone screening if the child was 
adopted or not a full sibling, or had a parent-reported 
diagnosis of autism, a major hearing impairment, a 
marked medical illness such as cancer, Down’s Syn-
drome, or intellectual disability (“mental retardation” 
or IQ less than 70). 
 
As the initial screening phase involved the collec-
tion of relatively non-invasive parent-report interview 
and questionnaire data to be stored in de-identified 
form, consent was required only from parent partici-
pants at this stage. After explanation of study proce-
dures, informed consent was obtained from respon-
dent parents and documented by study staff prior to 
an initial ADHD screening interview. Parents were 
informed that phase 1 of the study would include the 
initial telephone interview plus questionnaires regard-
ing their children. They were also informed that they 
and their family may later be invited to participate in 
additional assessments on the basis of their responses 
to the initial telephone questions. A subset of families 
was eventually selected for more detailed phenotypic 
and genetic study, which required written consent 
from parents and their adult offspring participants, 
and assent from minor children. The current manu-
script uses only the phase 1 parent-report screening 
data. Ethical approval for this study was obtained 
through the Washington University Human Research 
Protection Office, which reviewed and approved the 
study protocols, including consent procedures. 
 
The MO-BIGSIBS sample includes 22,581 off-
spring, some of them young adults, with complete 
data on sex, age at screening, and screening interview 
ADHD items (21). The current analyses focus on 
children and adolescents age 7-17 years (n=5,744) at 
assessment, who have complete data on sex, age, life-
time ADHD symptoms from the screening interview, 
and relevant questionnaire items. Of the 5,744 sub-
jects, 98% are Caucasian, 2% are African-American, 
and less than 1% report other races/ethnicities. Fifty-
two percent of study subjects are male. 
 
Measures 
In the initial screening phase, the best informant par-
ent (usually mother) reported on lifetime occurrence 
of each of the standard 18 DSM-IV ADHD symp-
toms for each of their offspring.  Each lifetime 
ADHD symptom was counted as positive only if 
there was reported impairment at home and/or 
school at some point in the child’s life. The screening 
questions were taken from the ADHD section of the 
Missouri Assessment of Genetics Interview for Chil-
dren (MAGIC), which has excellent reliability for 
parent-reported ADHD (22). A subset of parent in-
formants subsequently completed several question-
naires regarding the offspring, including the Strengths 
and Weaknesses of ADHD-symptoms and Normal-
behavior (SWAN) scale, the Social Responsiveness 
Scale (SRS), and the Child Behavior Checklist 
(CBCL). 
 
The CBCL covers a wide range of problem behav-
iors (23), and the SRS is a 65-item quantitative meas-
ure of autistic traits (24, 25). SRS score is highly corre-
lated with algorithm scores from the Autism Diagnos-
tic Interview-Revised (ADI-R) (24). The SWAN (26) 
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includes 18 items based on DSM-IV ADHD symp-
toms plus additional items assessing oppositional-
defiant behaviors (9 items) and three items related to 
sluggish cognitive tempo. SWAN items are scored on 
a seven-point scale (-3 to +3) in which positive scores 
indicate the presence of problem behaviors and nega-
tive scores indicate better than average behaviors. 
Data from the SWAN was used to define current 
DSM-IV-like ADHD diagnoses, and data from the 
screener was used to define lifetime DSM-IV-like 
ADHD diagnoses.  It was not possible to apply strict 
DSM-IV criteria in determining ADHD diagnoses 
since information about age-of-onset and current 
impairment specifically from ADHD symptoms was 
not collected. However, the lifetime ADHD symptom 
data from the screening interview and current symp-
tom data from the SWAN allowed us to assign sub-
jects to ADHD-like diagnoses using the DSM-IV 
ADHD symptom criterion. From the screener data, a 
diagnosis of Lifetime DSM-IV inattentive ADHD 
(DSM-Life-IA) was assigned if there were at least six 
lifetime inattentive (IA) symptoms and less than six 
lifetime hyperactive-impulsive (HI) symptoms based 
on the screening interview. Lifetime DSM-IV 
 
 
 
 
 
Figure 1. Mean CBCL subscale T-Scores for children and adolescents 
with DSM-IV Inattentive (IA), Hyperactive-Impulsive (HY), and com-
bined type (SC) ADHD. The SC subtype consistently scores higher than 
the IA or HY subtypes. 
 
 
 
hyperactive-impulsive type (DSM-Life-HI) was as-
signed if there were at least six HI symptoms but less 
than six IA symptoms. Lifetime combined type 
ADHD (DSM-Life-C) was assigned if there were at 
least six symptoms in each of the two categories (IA 
and HI). 
 
Using similar algorithms, current DSM-IV-like di-
agnoses (DSM-IA, DSM-HI, and DSM-C) were as-
signed using the DSM-IV ADHD symptom items 
from the SWAN. SWAN-based ADHD symptoms 
were counted as present if the parent rated the child 
at a level of 1 or higher, an actually stringent cutoff 
that typically corresponds to the 90th-95th percentile 
for each item (21).  
 
 
Data Analysis 
Analyses were conducted using STATA 12 and SAS 
9.3. We used ANOVA to Compare CBCL syndrome 
subscale T-scores across the four subject groups (un-
affected individuals and the three ADHD subtypes), 
with a conservative Bonferoni correction for multiple 
testing and with standard errors adjusted for cluster-
ing by family. Conversely, we considered whether a 
rule could be developed from the SRS and CBCL 
subscale data, to distinguish DSM-IV inattentive and 
hyperactive-impulsive subtypes, again taking into 
account the known correlation between the two 
symptom domains. To that purpose, we use seem-
ingly-unrelated bivariate probit regression with the 
robust clustering option (on family), beginning with a 
full model consisting of age, SRS, and the eight CBCL 
syndrome scale scores. This allowed us to test if the 
relationship between specific variables (e.g., age or 
subscale score) and the liability to HI was the same as 
with the liability to IA. The analyses were conducted 
separately for males and females. The output from 
this analysis consists of two predicted means (probit 
scale, akin to predicted scores from linear regression) 
for each individual subject, one for IA and one for 
HI. Receiver Operating Characteristics (ROC) Curves 
were used to assess the sensitivity and specificity of 
these probit scores in predicting elevated IA and HI 
symptoms. The two probit scores were then used in a 
linear discriminant analysis to assess the ability to 
distinguish between DSM-IV ADHD subtypes. 
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Table 1. Parameter estimates for females, ordered bivariate probit regression, predicting 
inattentive and hyperactive-impulsive symptom counts.  
* = Retained for subsequent analyses. 
 
Predictor of Inattentive 
Symptom Count Coefficient 
Standard 
Error z p 95% CI 
* SRS 0.022 0.003 8.19 <0.001 0.017 to 0.027 
* Anxious/Depressed -0.025 0.009 -2.91 0.004 -0.042 to -0.008 
* Withdrawn/Depressed -0.030 0.007 -4.48 <0.001 -0.043 to -0.017 
* Somatic Complaints 0.022 0.006 3.60 <0.001 0.010 to 0.034 
* Attention problems 0.149 0.008 18.35 <0.001 0.133 to 0.165 
* Rule-Breaking 0.030 0.008 3.82 <0.001 0.015 to 0.045 
   Age  -0.020 0.009 -2.32 0.020 -0.037 to -0.003 
   Social Problems -0.012 0.009 -1.36 0.175 -0.029 to 0.005 
   Thought Problems  -0.020 0.008 -2.44 0.015 -0.036 to -0.004 
   Aggressive Behavior -0.011 0.009 -1.43 0.154 -0.027 to 0.004 
Predictor of Hyperac-
tive-Impulsive Symptom 
Count Coefficient 
Standard 
Error 
 
 
z 
 
 
p 
 
 
95% CI 
* Age -0.031 0.009 -3.25 0.001 -0.049 to -0.012 
* SRS  0.021 0.003 7.86 <0.001 0.015 to 0.026 
* Withdrawn/Depressed  -0.067 0.008 -7.94 <0.001 -0.084 to -0.051 
* Thought Problems  0.021 0.008 2.76 0.006 0.006 to 0.036 
* Attention Problems 0.057 0.007 8.28 <0.001 0.044 to 0.071 
* Aggressive Behavior 0.055 0.009 6.30 <0.001 0.038 to 0.072 
   Social Problems  0.009 0.009 1.00 0.319 -0.009 to 0.027 
   Somatic Complaints 0.013 0.006 2.04 0.041 0.001 to 0.025 
   Anxious/Depressed 0.003 0.009 0.35 0.724 -0.014 to 0.020 
   Rule-Breaking -0.007 0.009 -0.78 0.434 -0.025 to 0.011 
 
 
 
 
 
Table 2. Parameter estimates for males, ordered bivariate probit regression, predicting 
inattentive and hyperactive symptom counts.  
* = Retained for subsequent analyses. 
 
Predictor of Inattentive 
Symptom Count Coefficient 
Standard 
Error z p 95% CI 
* SRS 0.021 0.002 9.84 <0.001 0.017 to 0.025 
* Anxious/Depressed -0.027 0.007 -3.74 <0.001 -0.042 to -0.013 
* Withdrawn/Depressed -0.017 0.006 -2.78 0.005 -0.029 to -0.005 
* Thought Problems 0.028 0.007 -3.86 <0.001 -0.043 to -0.014 
* Attention problems 0.159 0.008 19.31 <0.001 0.143 to 0.176 
   Somatic Complaints 0.001 0.007 0.22 0.827 -0.012 to 0.015 
   Social Problems -0.006 0.008 -0.67 0.501 0.022 to 0.011 
   Age 0.000 0.008 0.04 0.968 -0.015 to 0.016 
   Rule-Breaking  0.016 0.008 1.85 0.065 -0.001 to 0.032 
   Aggressive Behavior -0.012 0.007 -1.63 0.103 -0.026 to 0.002 
Predictor of Hyperac-
tive-Impulsive Symptom 
Count Coefficient 
Standard 
Error 
 
 
z 
 
 
p 
 
 
95% CI 
* Age -0.059 0.008 -7.02 <0.001 -0.075 to -0.042 
* SRS  0.019 0.002 8.78 <0.001 0.015 to 0.024 
* Withdrawn/Depressed    -0.060 0.007 -8.57 <0.001 -0.073 to -0.046 
* Attention Problems 0.087 0.006 13.76 <0.001 0.075 to 0.100 
* Aggressive Behavior 0.045 0.007 6.25 <0.001 0.031 to 0.059 
   Anxious/Depressed -0.015 0.007 -2.03 0.042 -0.029 to -0.001 
   Somatic Complaints   -0.012 0.007 -1.85 0.064 -0.025 to 0.001 
   Social Problems 0.011 0.008 1.35 0.178 -0.005 to 0.027 
   Thought Problems   0.013 0.007 1.88 0.060 -0.001 to 0.026 
   Rule-Breaking  -0.004 0.008 -0.54 0.590 -0.021 to 0.012 
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Given the relatively high levels of correlation be-
tween them, we also conducted a principal compo-
nents analysis of SRS total score and CBCL subscale 
scores in a preliminary assessment of whether a sum-
mary measure of these individual scales and subscales 
could be used to distinguish between ADHD sub-
types.  We implemented principal components analy-
sis using the principal-component factor (pcf) method 
available in STATA, which analyzes a correlation 
matrix in which the communalities (numbers on the 
diagonal of the correlation matrix) are assumed to be 
1. We examined the relationship between the first 
unrotated factor from this analysis and the first factor 
from the SWAN principal components analysis for 
individuals with only inattentive symptoms, only hy-
peractive-impulsive symptoms, and both types of 
symptoms.  
 
 
Results 
Thirteen percent of the 5,744 subjects meet symptom 
criteria for lifetime ADHD based on the screening 
interview, and 11% for current ADHD based on the 
SWAN. The current inattentive group (DSM-IA) in-
cludes 119 females and 213 males, the hyperactive-
impulsive (DSM-HI) group includes 26 females and 
52 males, and the combined type ADHD group 
(DSM-C) includes 31 females and 94 males. The base-
line (currently unaffected) group includes 2,602 fe-
males and 2,527 males. 
 
As seen in previous studies, subjects with combined 
type ADHD have more severe psychopathology than 
other ADHD subtypes (Figure 1). Not surprisingly, 
the highest separation is attained for the CBCL atten-
tion problems and aggressive behavior subscales. 
There are no statistical differences between the DSM-
HI and DSM-IA subtypes on the social problems and 
rule-breaking behavior subscales. Although clearly 
different from baseline, we find no difference be-
tween the DSM-IA, DSM-HI, and DSM-C subtypes 
on the withdrawn/depressed and the somatic com-
plaints subscales. Finally, there is a gradual increase in 
severity on the anxious/depressed subscale, in the 
order baseline < DSM-IA < DSM-HI < DSM-C, but 
without clear group separation.  
 
Bivariate ordered probit regression models are 
summarized in Tables 1-2. In females, when predict-
ing inattentive symptom counts, we retained SRS 
score as well as scores on five CBCL subscales: anx-
ious/depressed, withdrawn/depressed, somatic com-
plaints, attention problems, and rule-breaking. In the 
model for hyperactivity symptoms, we retained age, 
SRS and four CBCL subscales: withdrawn/ depressed, 
thought problems, attention problems, and aggressive 
behavior. The residual correlation (between the IA and 
HI latent dimensions) was 0.33 (95% CI: 0.27 – 0.41). 
Follow-up ROC analyses for these two models to 
predict the presence or absence of six of more inat-
tentive or hyperactive-impulsive symptoms, respec-
tively, show good specificity and sensitivity 
(AUC=0.93 and 0.90). 
The residual correlation between the IA and HI la-
tent dimensions was comparable in the male subsam-
ple (0.39, 95% CI: 0.33 – 0.45). There were significant 
associations of the latent inattentive dimension with 
SRS score and scores on the CBCL subscales for 
anxious/depressed, withdrawn/  depressed, thought 
problems and attention problems. For the HI dimen-
sion, age, SRS and the CBCL subscale scores for 
withdrawn/depressed, attention problems and aggres-
sive behavior were significant.  Follow-up ROC analy-
ses using the predicted values from these models to 
predict the presence or absence of six or more inat-
tentive or hyperactive-impulsive symptoms show, as 
for females, good specificity and sensitivity 
(AUC=0.93 and 0.91, for inattention and hyperactiv-
ity-impulsivity, respectively). 
 
We then used linear discriminant analysis to assess 
the ability to distinguish between ADHD subtypes 
using information from age, gender, the SRS and the 
CBCL subscales (Table 4). The measures used in the 
discriminant analyses are the predicted means (probit) 
from the models described previously. Note that dif-
ferent predictors are used depending on the outcome 
measure (e.g., inattentive vs. hyperactive/ impulsive 
symptoms) and gender, as described above.  Based on 
these measures which were not designed to assess 
ADHD, the ability to discriminate between unaffected 
and the combined subtype was very good, with posi-
tive predictive values (PPV) and negative predictive 
values (NPV) over 83% and 96%, respectively. In 
females, the lowest PPV was observed for discrimi-
nating between the inattentive and combined sub-
types. In males, the lowest PPV was for the contrast 
between the hyperactive/impulsive and combined 
subtypes. 
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Table 4. Percentage correct ADHD subtype classification based on 
scores derived from age, gender, SRS, and CBCL subscales.  
Base=baseline (unaffected); IA=inattentive subtype; HI= hyperactive-
impulsive subtype; CB= combined subtype ADHD.  Linear discriminant 
analysis readily distinguishes between ADHD subtypes using informa-
tion from age, gender, SRS score and CBCL subscales. The ability to 
discriminate between unaffected and combined subtype ADHD was 
very good, with positive predictive values (PPV) and negative predic-
tive values (NPV) over 83% and 96%, respectively. In females, the 
lowest PPV was observed for discriminating between inattentive and 
combined subtypes. In males, the lowest PPV was for the contrast 
between the hyperactive/impulsive and combined subtypes 
 
Gender Contrast Base IA HI CB PPV NPV 
Females Base vs. IA 93% 80% -- -- 80% 93% 
 Base vs. HI 88% -- 65% -- 65% 88% 
 Base vs. CB 96% -- -- 89% 89% 96% 
 IA vs. HI -- 75% 87% -- 87% 75% 
 IA vs. CB -- 78% -- 56% 56% 78% 
 HI vs. CB -- -- 78% 74% 74% 78% 
Males Base vs. IA 89% 73% -- -- 73% 89% 
 Base vs. HI 89% -- 73% -- 74% 90% 
 Base vs. CB  95% -- -- 83% 83% 96% 
 IA vs. HI -- 76% 67% -- 67% 76% 
 IA vs. CB -- 77% -- 67% 67% 77% 
 HI vs. CB -- -- 74% 66% 65% 73% 
 
 
 
A principal components analysis of the 18 SWAN 
current ADHD symptom items yields the well docu-
mented two factor solution, accounting for approxi-
mately 80% of the variance (Table 3). The factor load-
ings are remarkably close to what we observe for the 
lifetime ADHD screener data. The first component 
represents “severity”, with approximately uniform 
factor loadings across all items. The second compo-
nent assigns a positive loading to inattentive items and 
a negative loading to hyperactive-impulsive items, and 
differentiates between predominantly inattentive ver-
sus hyperactive-impulsive, with the same overall level 
of severity. The factor loadings are fairly uniform, but 
not identical.  Thus, the correlation between simple 
symptom counts and factor scores is very high 
(>95%), but imperfect. The implication is that a 
number of children could be “misdiagnosed” under a 
simple counting scheme that assigns equal weight to 
all items (in Figure 2, a number of such “misdiagno-
ses” are visible). 
There are strong correlations and partial correla-
tions between the SRS total score and CBCL sub-
scores (Table 5). Figure 3 plots the predicted first 
factor score (without rotation) derived from these 
measures, against the first factor score for the 18 
SWAN ADHD items. Three curves are shown, for 
individuals with zero hyperactive/impulsive symp-
toms (green), zero inattentive symptoms (orange), and 
at least one symptom of each category (red). Inas-
much as SWAN Factor 1 correlates very highly with 
the actual number of symptoms, this shows that, for 
the same number of symptoms, individuals who pre-
sent with both inattentive and hyperactive/impulsive 
symptoms also tend to present with higher severity 
with respect to a summary score of the SRS and the 
CBCL subscales. Note that at low SWAN severity 
scores, the lines are almost flat, and the mean SRS-
CBCL factor scores are not different between groups. 
At higher SWAN severity scores, the slopes of the 
lines increase and there is a statistically significant 
separation of the predicted SRS-CBCL severity factor 
scores between groups, with the lowest severity in the 
HI-only group, intermediate severity in the IA-only 
group, and the highest severity in the group with both 
IA and HI symptoms. 
 
There are 250 individuals in our sample with at total 
of at least 6 current DSM-IV ADHD symptoms, who 
do not meet criteria for a specific DSM-IV ADHD 
subtype. On average, these 250 individuals have four 
inattentive and three hyperactive-impulsive symp-
toms. In Figure 2, these subjects would be near the  
 
 
Table 3. Principal Components Analysis of SWAN items. 
(N=5744 children) Principal components analysis of the 
18 SWAN ADHD symptom items yields the well docu-
mented two factor solution, accounting for approxi-
mately 80% of the variance. The first principal compo-
nent is severity score, with loadings approximately equal. 
The second associates positive loadings to inattentive 
items and negative loadings to hyperactivity items. 
Abbreviated version of item content is shown in the left 
column. 
 
Swan Item 
 
Factor 1 Factor 2 Uniqueness 
1. Careless mistakes 0.80 0.36 0.23 
2. Sustain attention 0.85 0.28 0.19 
3. Listen 0.86 0.14 0.25 
4. Finish work 0.83 0.37 0.17 
5. Organize tasks 0.82 0.41 0.16 
6. Sustain effort 0.82 0.35 0.21 
7. Keep track of things 0.82 0.35 0.20 
8. Ignore stimuli 0.79 0.17 0.34 
9. Remember activities 0.83 0.26 0.23 
10. Sit still 0.86 -0.20 0.23 
11. Stay seated 0.87 -0.21 0.19 
12. Running/Climbing 0.79 -0.22 0.33 
13. Play quietly 0.82 -0.35 0.20 
14. Control activity 0.85 -0.35 0.16 
15. Control talking 0.80 -0.37 0.23 
16. Control blurting 0.83 -0.32 0.21 
17. Await turn 0.84 -0.35 0.17 
18. Control intruding 0.80 -0.33 0.26 
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Table 5. Correlations (bottom) and partial correlations (top) between SRS score and CBCL subscale scores.  
All correlations significant with p < 0.0001 (Bonferoni adjusted). Correlations between the SRS score and CBCL 
scales on N = 4982; Correlations between CBCL subscales on N = 5737. Only partial correlations greater than 0.10 
are shown. Note that while the overall correlation shows Rule-breaking (Rule) is positively correlated with the 
Anxious/Depressed (Anx/Dep) scale, the partial correlation indicates these two scales are negatively correlated 
after controlling for other psychopathology. CBCL subscale abbreviations: Attention= Attention problems; Thought= 
Thought problems; Anx/Dep= Anxious/Depressed; With/Dep=Withdrawn/Depresssed; Somatic=Somatic com-
plaints; Social= Social problems; Rule= Rule-breaking; Aggr=Aggressive behavior 
 
 SRS Attention Thought Anx/Dep With/Dep Somatic Social Rule Aggr 
SRS -- -- 0.2874 0.1302  0.3398  0.2891   
Attention 0.6300  -- -- 0.1769    0.1410 0.1253 0.1647 
Thought 0.5305 0.5133  -- -- 0.1574  0.1719    
Anx/Dep 0.5399 0.4037 0.4892 -- -- 0.2387 0.1970 0.2700 - 0.1203 0.1368 
With/Dep 0.6140 0.4098 0.4118 0.5438 -- -- 0.1372  0.1308  
Somatic 0.3539 0.3160 0.4119 0.4617 0.3882 -- --    
Social 0.6728 0.5801 0.4918 0.6071 0.5092 0.4145 -- --  0.2236 
Rule 0.4354 0.5040 0.3982 0.3073 0.3757 0.2728 0.4409  -- -- 0.5246 
Aggr 0.5700 0.5967 0.4934 0.5006 0.4390 0.3706 0.6274  0.6867 -- -- 
 
 
 
center of the scatter-plot, just below the affection cut-
off by DSM-IV symptom criteria. Interestingly, this 
group appears to have higher severity of co-occurring 
psychopathology than pure inattentive or pure hyper-
active-impulsive subjects with equivalent total ADHD 
severity (Figure 3). 
 
 
Discussion 
This analysis supports the continued use of ADHD 
subtypes, or “presentations”, as they may be called in 
DSM-5 (20), as suggested by differences in co-
occurring psychopathology.  As different psychopa-
thology subscales were more or less associated with 
IA versus HI symptoms (and with ADHD subtypes), 
the pattern of ADHD symptom presentation may 
inform clinicians about risk for various co-occurring 
conditions and overall severity or impairment. We 
observe ADHD subtype differences in severity of co-
occurring psychopathology, not only at the extreme, 
but also in the range of mild to moderately severe 
ADHD. Children with low-level symptoms in both 
the inattentive and the hyperactive-impulsive domain, 
but with a significant number of total symptoms 
overall, are likely to be just as impaired (or more im-
paired) than individuals with the same overall total 
ADHD severity but with symptoms in only one of the 
two domains. 
Our results underscore the fact that current diag-
nostic criteria may fail to identify a potentially im-
paired group of children with significant levels of 
both inattention and hyperactivity-impulsivity. These 
children, who could be classified as ADHD Not Oth-
erwise Specified (ADHD-NOS) according to DSM-
IV, have significant impairment and co-occurring 
problems. As these individuals have, on average, 4 
inattentive and 3 hyperactive-impulsive symptoms, 
they could also be described as having a mild com-
bined subtype of ADHD. In a separate Missouri 
population-based sample, analyses indicated that a 
“mild combined” form of ADHD was one of 3 clini-
cally impaired latent class ADHD subtypes (5), and 
was also characterized by elevated levels of autistic 
traits (9). On the other hand, it could be argued that 
some children with moderate ADHD symptoms may 
not have true ADHD but rather another disorder 
with symptoms that overlap with ADHD. Arguably, 
depression or oppositional-defiant disorder, for ex-
ample, might respectively lead to high internalizing or 
externalizing symptoms, and mimic the pure inatten-
tive or pure hyperactive-impulsive ADHD subtype. 
Differences in comorbid psychopathology between 
subtypes (Figure 3) could be due to the inclusion of 
individuals with disorders other than ADHD that 
mimic ADHD symptoms.  
The CBCL and the SRS did rather well in distin-
guishing ADHD subtypes in this population-based 
sample, even though they were not designed for that 
purpose. This supports the use of quantitative meas-
ures of ADHD (such as the SWAN) and  other forms 
of psychopathology (i.e., SRS, CBCL) in order to 
obtain a more complete picture of overall severity and 
co-occurring problems. In particular, even after re-
moving SRS items with wording that may pick up on 
ADHD-like symptoms, SRS scores remain mildly 
elevated for hyperactive-impulsive and inattentive 
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ADHD, and even further elevated in combined type 
ADHD (9). Children with ADHD symptoms plus 
very high (clinically elevated) SRS scores may have a 
combination of ADHD plus a true autism spectrum 
disorder. However, it may be that moderately elevated 
SRS scores in the context of ADHD are sometimes 
indicators of general psychosocial impairment, social 
impairment directly due to ADHD symptoms, and/or 
social anxiety symptoms, resulting in SRS scores that 
are above normal but not in a range indicating a clini-
cal diagnosis of autism spectrum disorder. The SRS 
may be a measure of overall level of psychopathology 
across its entire scoring range, such that children with 
the highest severity levels of ADHD, or even the 
highest levels of overall psychopathology, will always 
show some autistic-like social impairment. Within this 
conceptualization, children with autism might be con-
sidered to have the most severe and pervasive form of 
childhood psychopathology. 
 
 
 
 
Figure 2. Relationship between severity and symptom type factors 
derived from the SWAN, and DSM-IV diagnosis.  Each circle is an ob-
servation. Color indicates DSM-IV subtype (Blue= No diagnosis, Green= 
Inattentive, Orange= Hyperactive-Impulsive, Red= Combined type 
ADHD).  Black lines: Created using linear regression of factor 2 on 
factor 1, using only those subjects with exactly 6 inattentive or exactly 
6 hyperactive-impulsive symptoms. Some individuals in the center of 
the plot do not meet the DSM-IV symptom criterion (<6 symptoms in 
both categories), but actually have a total severity factor score equal 
to some individuals classified as having inattentive or hyperactive-
impulsive type ADHD.  
 
 
This study has some limitations.  We could not con-
firm true DSM-IV ADHD diagnoses given the ab-
sence of age-of-onset and current impairment data, 
but the purpose of the current analyses was to exam-
ine the relationship between ADHD symptoms and 
co-occurring psychopathology, not to determine 
prevalence of categorical diagnoses defined exactly as 
in DSM-IV. Because we did not consider age-of-onset 
or impairment criteria, our estimated SWAN-based 
ADHD prevalence (11%) could be slightly higher 
than the number meeting full criteria for true DSM-
IV ADHD. However, lifetime ADHD symptoms were 
not considered positive unless impairment at home 
and/or school was reported, and 95% of subjects 
classified as having current ADHD based on the 
SWAN had at least one lifetime impairing ADHD 
symptom on the telephone screening interview, indi-
cating that most had a history of impairment from 
their ADHD symptoms. Therefore, we expect our 
estimates to be close to the true prevalence of DSM-
IV ADHD (with consideration of impairment) in 
Missouri children. Reasonably consistent with our 
estimates, the United States Centers for Disease Con-
trol and Prevention (CDC) reported an ADHD 
prevalence of 10.8 percent for 4-to-17-year-old chil-
dren in Missouri for the year 2007 based on parent-
reported history of ADHD diagnosis (27), and an 
estimated 6.7 percent of Missouri 14-to-17-year-old 
children were taking medication for ADHD in 2007-
2008 (28).  It may also be argued that our method of 
ascertainment (large families) might limit the gener-
alizability of this study. Although our sample is not 
subject to the referral bias that occurs with clinic-
based samples, our sample was selected based on large 
family size and availability of parents for potential 
future genetic study. There is also the possibility that 
parents who have ADHD symptoms themselves 
might be less likely to return questionnaires. However, 
we found no evidence for selection bias based on 
ADHD diagnosis in this sample (21). The sample is 
also almost entirely Caucasian, so it is unclear whether 
the current findings are generalizable to individuals of 
other racial and ethnic backgrounds. Also, we were 
unable to control for socioeconomic factors since we 
did not have socioeconomic data regarding the study 
subjects. 
ADHD subtypes are useful concepts in terms of 
understanding a child’s symptoms and formulating 
appropriate educational plans and behavioral inter-
ventions. However, the requirement that a child meet 
a specific DSM-IV ADHD subtype category in order 
to be diagnosed and treated is not satisfactory. The 
current study suggests it may be important to consider 
both overall severity and relative contribution of inat-
tentive vs. hyperactive-impulsive symptoms.  Indeed, 
if only total severity is used, it is possible that some 
clinically impaired individuals with impairing inatten-
tive-only symptoms might be missed. However if at 
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least 6 symptoms in one or the other symptom cate-
gory is required, then clinically impaired individuals 
with just a few symptoms in each category (i.e., 5 
inattentive plus 5 hyperactive-impulsive symptoms) 
may be missed. These individuals may be best identi-
fied by measures of total severity (i.e., a total symp-
tom count or a quantitative symptom rating based on 
an instrument such as the SWAN). 
 
 
 
Figure 3. Plot of the first factor score from a factor analysis of SRS total 
score and CBCL subscores, against the first factor score for the 18 
SWAN ADHD symptoms. The curves were built using fractional poly-
nomials (shaded area: approximate 99% confidence interval) and 
indicate predicted mean SRS-CBCL factor score given the SWAN sever-
ity score. Three curves are shown, for individuals with zero hyperac-
tive/impulsive symptoms (green), zero inattentive symptoms (orange), 
and at least one symptom of each category (red). Inasmuch as SWAN 
Factor 1 correlates very highly with the overall number of symptoms, 
this shows that, for the same number of symptoms, individuals who 
present with both inattentive and hyperactive/ impulsive symptoms 
tend to present with higher severity with respect to the SRS score and 
CBCL subscales. 
 
 
In terms of clinical relevance, we found that chil-
dren with mild to moderate ADHD symptoms may 
have different levels of co-occurring psychopathology 
depending on ADHD subtype, those with both inat-
tentive and hyperactive-impulsive symptoms having 
the highest overall levels. Also, children and adoles-
cents who have several ADHD symptoms but do not 
technically meet current ADHD criteria due to lack of 
6 symptoms in one or the other symptom category 
should not be overlooked. In the DSM-IV context, 
such individuals could be given a diagnosis of ADHD 
Not Otherwise Specified (NOS) if they have clinically 
significant impairment from their ADHD symptoms. 
Proposed changes for DSM-5 include replacement of 
ADHD-NOS by a “Not Elsewhere Classified (NEC)” 
diagnosis which could be used to describe individuals 
who fail to meet the full ADHD criteria due to sub-
threshold number of symptoms (20). It will be impor-
tant for clinicians to consider using the new ADHD-
NEC diagnosis for clinically impaired individuals who 
have approximately 6-10 total ADHD symptoms but 
less than six symptoms in each of the two symptom 
domains.  
 
 
 
References 
 
1. McLoughlin G, Ronald A, Kuntsi J, Asherson P, Plomin R. Genetic 
support for the dual nature of attention deficit hyperactivity disorder: 
substantial genetic overlap between the inattentive and hyperactive-
impulsive components. Journal of abnormal child psychology. 
2007;35(6):999-1008.  
 
2. Biederman J, Faraone SV, Doyle A, Lehman BK, Kraus I, Perrin J, et 
al. Convergence of the Child Behavior Checklist with structured 
interview-based psychiatric diagnoses of ADHD children with and 
without comorbidity. J Child Psychol Psychiatry. 1993;34(7):1241-51.  
 
3. Gross-Tsur V, Goldzweig G, Landau YE, Berger I, Shmueli D, 
Shalev RS. The impact of sex and subtypes on cognitive and 
psychosocial aspects of ADHD. Developmental medicine and child 
neurology. 2006;48(11):901-5.  
  
4. Rohde LA, Biederman J, Zimmermann H, Schmitz M, Martins S, 
Tramontina S. Exploring ADHD age-of-onset criterion in Brazilian 
adolescents. Eur Child Adolesc Psychiatry. 2000;9(3):212-8. Epub 
2000/11/30. 
 
5. Volk HE, Henderson C, Neuman RJ, Todd RD. Validation of 
population-based ADHD subtypes and identification of three 
clinically impaired subtypes. Am J Med Genet B Neuropsychiatr 
Genet. 2006;141B(3):312-8. Epub 2006/03/10. 
 
6. Neuman RJ, Sitdhiraksa N, Reich W, Ji TH, Joyner CA, Sun LW, et 
al. Estimation of prevalence of DSM-IV and latent class-defined 
ADHD subtypes in a population-based sample of child and 
adolescent twins. Twin Res Hum Genet. 2005;8(4):392-401. Epub 
2005/09/24. 
 
7. Todd RD, Sitdhiraksa N, Reich W, Ji TH, Joyner CA, Heath AC, et 
al. Discrimination of DSM-IV and latent class attention-
deficit/hyperactivity disorder subtypes by educational and cognitive 
performance in a population-based sample of child and adolescent 
twins. Journal of the American Academy of Child and Adolescent 
Psychiatry. 2002;41(7):820-8.  
 
8. Volk HE, Neuman RJ, Todd RD. A systematic evaluation of ADHD 
and comorbid psychopathology in a population-based twin sample. 
Journal of the American Academy of Child and Adolescent 
Psychiatry. 2005;44(8):768-75. Epub 2005/07/22.  
 
9. Reiersen AM, Constantino JN, Volk HE, Todd RD. Autistic traits in 
a population-based ADHD twin sample. J Child Psychol Psychiatry. 
2007;48(5):464-72. Epub 2007/05/16. 
 
10. Reich W, Neuman RJ, Volk HE, Joyner CA, Todd RD. Comorbidity 
between ADHD and symptoms of bipolar disorder in a community 
sample of children and adolescents. Twin Res Hum Genet. 
2005;8(5):459-66.  
 
11. Todd RD, Huang H, Smalley SL, Nelson SF, Willcutt EG, 
Pennington BF, et al. Collaborative analysis of DRD4 and DAT 
genotypes in population-defined ADHD subtypes. J Child Psychol 
Psychiatry. 2005;46(10):1067-73.  
ADHD Subtype Definitions & Psychopathology 
13 
 
 
12. Todd RD, Lobos EA, Sun LW, Neuman RJ. Mutational analysis of 
the nicotinic acetylcholine receptor alpha 4 subunit gene in attention 
deficit/hyperactivity disorder: evidence for association of an intronic 
polymorphism with attention problems. Molecular psychiatry. 
2003;8(1):103-8.  
 
13. Todd RD, Neuman RJ. Gene-environment interactions in the 
development of combined type ADHD: evidence for a synapse-based 
model. Am J Med Genet B Neuropsychiatr Genet. 2007;144B(8):971-
5.  
 
14. Todd RD, Huang H, Todorov AA, Neuman RJ, Reiersen AM, 
Henderson CA, et al. Predictors of stability of attention-
deficit/hyperactivity disorder subtypes from childhood to young 
adulthood. Journal of the American Academy of Child and 
Adolescent Psychiatry. 2008;47(1):76-85. Epub 2008/01/05. 
 
15. Hudziak JJ, Heath AC, Madden PF, Reich W, Bucholz KK, Slutske 
W, et al. Latent class and factor analysis of DSM-IV ADHD: a twin 
study of female adolescents. Journal of the American Academy of 
Child and Adolescent Psychiatry. 1998;37(8):848-57. Epub 
1998/08/08. 
. 
16. Rasmussen ER, Neuman RJ, Heath AC, Levy F, Hay DA, Todd RD. 
Replication of the latent class structure of Attention-
Deficit/Hyperactivity Disorder (ADHD) subtypes in a sample of 
Australian twins. J Child Psychol Psychiatry. 2002;43(8):1018-28.  
 
17. Todd RD, Rasmussen ER, Neuman RJ, Reich W, Hudziak JJ, 
Bucholz KK, et al. Familiality and heritability of subtypes of attention 
deficit hyperactivity disorder in a population sample of adolescent 
female twins. The American journal of psychiatry. 2001;158(11):1891-
8.  
 
18. Neuman RJ, Todd RD, Heath AC, Reich W, Hudziak JJ, Bucholz 
KK, et al. Evaluation of ADHD typology in three contrasting 
samples: a latent class approach. Journal of the American Academy of 
Child and Adolescent Psychiatry. 1999;38(1):25-33.  
 
19. Hurtig T, Ebeling H, Taanila A, Miettunen J, Smalley SL, McGough 
JJ, et al. ADHD symptoms and subtypes: relationship between 
childhood and adolescent symptoms. Journal of the American 
Academy of Child and Adolescent Psychiatry. 2007;46(12):1605-13. 
Epub 2007/11/22. 
 
20. Tannock R. Rethinking ADHD and LD in DSM-5: proposed changes 
in diagnostic criteria. Journal of learning disabilities. 2013;46(1):5-25. 
Epub 2012/11/13.  
 
21. Ramtekkar UP, Reiersen AM, Todorov AA, Todd RD. Sex and age 
differences in attention-deficit/hyperactivity disorder symptoms and 
diagnoses: implications for DSM-V and ICD-11. Journal of the 
American Academy of Child and Adolescent Psychiatry. 
2010;49(3):217-28 e1-3.  
 
22. Todd RD, Joyner CA, Heath AC, Neuman RJ, Reich W. Reliability 
and stability of a semistructured DSM-IV interview designed for 
family studies. Journal of the American Academy of Child and 
Adolescent Psychiatry. 2003;42(12):1460-8.  
 
23. Achenbach TM, Rescorla LA, editors. Manual for the ASEBA 
School-Age Forms & Profiles. Burlington, VT: University of 
Vermont, Research Center for Children, Youth, & Families; 2001. 
 
24. Constantino JN, Davis SA, Todd RD, Schindler MK, Gross MM, 
Brophy SL, et al. Validation of a brief quantitative measure of autistic 
traits: comparison of the social responsiveness scale with the autism 
diagnostic interview-revised. Journal of autism and developmental 
disorders. 2003;33(4):427-33. Epub 2003/09/10. 
 
25. Constantino JN, Gruber CP. Social Responsiveness Scale (SRS) 
manual. Los Angeles, CA: Western Psychological Services; 2005. 
 
26. Swanson JM, Shnuck, S., Mann M., Carlson C., Hartman K., Sergeant 
J., Clevenger W., Wasdell M., McCleary R. Categorical and 
Dimensional Definitions and Evaluations of Symptoms of ADHD: 
The SNAP and the SWAN rating scales. [Accessed 2012 Nov 29]. 
Available from: www.adhd.net. 
 
27. Centers for Disease Control and Prevention. Increasing prevalence of 
parent-reported attention-deficit/hyperactivity disorder among 
children --- United States, 2003 and 2007. MMWR Morbidity and 
mortality weekly report. 2010;59(44):1439-43. Epub 2010/11/11.  
 
28. Visser SN, Blumberg SJ, Danielson ML, Bitsko RH, Kogan MD. 
State-based and demographic variation in parent-reported medication 
rates for attention-deficit/hyperactivity disorder, 2007-2008. 
Preventing chronic disease. 2013;10:E09. Epub 2013/01/26.  
 
 
 
 
Acknowledgements 
This work is dedicated to Richard D. Todd, Ph.D., 
M.D., who initiated data collection for this project. 
Dr. Todd died from complications of leukemia Au-
gust 22, 2008. This work was supported by award 
numbers R01-MH-067921 (PI-RDT, then AAT), 
R01-MH-083823 (PI-AAT), and K08-MH-080287 
(PI-AMR) from the National Institute of Mental 
Health (NIMH). The content is solely the responsibil-
ity of the authors and does not necessarily represent 
the official views of the NIMH or the National Insti-
tutes of Health.  
 
